The effect of poly(lactic-co-glycolic acid) (PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds.

Ideal scaffolds for bone tissue engineering require 3D interconnected porous structures, enough mechanical strength for hand of treatment as well as proper bioactivity and biodegradability. Calcium silicate (CaSiO3, CS) scaffolds have been studied for bone tissue engineering application due to their excellent bioactivity. However, the main disadvantages of CS scaffolds are their low mechanical strength and high alkaline ionic products. In this study, sintered CS scaffolds were prepared and coated with poly(lactic-co-glycolic acid) (PLGA), and the effect of PLGA coating on the mechanical, biodegradable, bioactive properties and drug release of porous CS scaffolds were investigated. The results showed that the PLGA-coated CS scaffolds maintained large pore size and high porosity. The compressive strength of PLGA/CS scaffolds was significantly improved compared to pure CS scaffolds, and increased with the increase of intrinsic viscosity and concentration of PLGA. In addition, the PLGA coating neutralized alkaline level resulted from the ionic products of CS scaffolds and reduced the pH value of biological solution during the degradation of scaffolds. It was found that PLGA/CS scaffolds still maintained excellent apatite-mineralization ability in SBF. Furthermore, the PLGA coating effectively inhibited the burst release and maintained a sustained release of drugs from the CS scaffolds. Our results indicate that the PLGA/CS scaffolds have great potential for bone tissue engineering application by the virtue of improved mechanical strength, and excellent bioactivity, degradation as well as drug-delivery property.

[1]  Aldo R Boccaccini,et al.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds , 2010, Journal of The Royal Society Interface.

[2]  Timothy A. Miller,et al.  The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. , 2005, Biomaterials.

[3]  Jung-Woog Shin,et al.  Comparison of physical, chemical and cellular responses to nano- and micro-sized calcium silicate/poly(ϵ-caprolactone) bioactive composites , 2008, Journal of The Royal Society Interface.

[4]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.

[5]  I. Silver,et al.  Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. , 2001, Biomaterials.

[6]  P. Deluca,et al.  Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres. , 1995, Journal of pharmaceutical and biomedical analysis.

[7]  M. Hartmann.  Ordered Mesoporous Materials for Bioadsorption and Biocatalysis , 2005 .

[8]  M. Lafage-Proust,et al.  Relationships between trabecular bone remodeling and bone vascularization: a quantitative study. , 2002, Bone.

[9]  A. Boccaccini,et al.  Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. , 2006, Biomaterials.

[10]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[11]  Si-yu Ni,et al.  A novel bioactive porous CaSiO3 scaffold for bone tissue engineering. , 2006, Journal of biomedical materials research. Part A.

[12]  Masakazu Kawashita,et al.  Novel bioactive materials with different mechanical properties. , 2003, Biomaterials.

[13]  Jiang Chang,et al.  Preparation and characterization of bioactive collagen/wollastonite composite scaffolds , 2005, Journal of materials science. Materials in medicine.

[14]  Chengtie Wu,et al.  A novel bioactive porous bredigite (Ca7MgSi4O16) scaffold with biomimetic apatite layer for bone tissue engineering , 2007, Journal of materials science. Materials in medicine.

[15]  P. Ducheyne,et al.  Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix. , 1997, Biomaterials.

[16]  Chengzhong Yu,et al.  Mesoporous bioactive glasses for controlled drug release , 2008 .

[17]  J. Jansen,et al.  Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[18]  Tadashi Kokubo,et al.  How useful is SBF in predicting in vivo bone bioactivity? , 2006, Biomaterials.

[19]  Jiang Chang,et al.  Preparation and characterization of bioactive and biodegradable Wollastonite/poly(D,L-lactic acid) composite scaffolds , 2004, Journal of materials science. Materials in medicine.

[20]  Jiang Chang,et al.  Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds. , 2004, Biomaterials.

[21]  Si-yu Ni,et al.  Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[22]  S. M. Li,et al.  Bioresorbability and biocompatibility of aliphatic polyesters , 1992 .

[23]  Jiang Chang,et al.  Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics. , 2008, Biomaterials.

[24]  Jiang Chang,et al.  In vitro degradation of porous degradable and bioactive PHBV/wollastonite composite scaffolds , 2005 .

[25]  N. Peppas,et al.  Physicochemical foundations and structural design of hydrogels in medicine and biology. , 2000, Annual review of biomedical engineering.

[26]  Chengtie Wu,et al.  The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds , 2011 .